Teon Therapeutics, a United States-based biopharmaceutical company, announced on Tuesday that it has named Glen Giovannetti as its new director.
Giovannetti has more than 36 years of leadership experience, industry expertise and board governance credentials subsequent to his retirement from Ernst & Young in December 2020.
Ken Horne, president and chief operating officer of Teon Therapeutics, said, 'We are excited to have Glen joining our board. His experience as lead partner on numerous IPOs and M&A transactions in the biotech industry will be invaluable for Teon as we navigate future growth opportunities.'
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation